In vivo, TRIM11 knockdown significantly reduced tumor growth in a subcutaneous xenograft model using BALB/c nude mice, highlighting its oncogenic role in gastric cancer progression via activation of the β-catenin signaling pathway [69]. Here, TRIM11 is linked to neoplasm.